What does the Chinese military want with your unborn baby’s genetic data?
By Arwa Mahdawi,
The Guardian
| 07. 10. 2021
The BGI group has used data from its popular prenatal test to help the People’s Liberation Army improve ‘population quality’ but they are far from the only ones normalizing eugenics
Your unborn baby is already being monetized
Could data harvested from millions of pregnant women pave the way for genetically enhanced super-soldiers? According to a recent Reuters investigation, BGI Group, the manufacturers of a popular prenatal test, is working with the Chinese military towards that very goal.
BGI group offers a test called Nifty (“Non-Invasive Fetal TrisomY”), which is offered in more than 50 countries and is used to look for genetic abnormalities such as Down’s syndrome early on in a pregnancy. According to Reuters, more than 8 million women have taken these tests, and BGI has used the genetic data it has collected to help the Chinese military improve “population quality”. Reuters reports that US government advisers have warned that access to this massive databank could “propel China to dominate global pharmaceuticals, and also potentially lead to genetically enhanced soldiers, or engineered pathogens to target the US population or food supply”. BGI has issued a statement rejecting these claims.
“China is stealing your intimate data for evil purposes” is a popular genre in western journalism – see, for...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...
By Dhruv Mehrotra , Wired | 08.03.2026
On March 13, 2025, Hugo Moreno-Mendez arrived at the McLennan County Probation Department in Waco, Texas, expecting a routine probation check-in. Instead, Immigration and Customs Enforcement officers were waiting to arrest him.
According to a criminal complaint reviewed by WIRED...
